Venclexta

Indicated For

AML, CLL/SLL

About This Medication

# Genentech Patient Foundation Patient Guide: How to Get Venclexta (venetoclax) at Low or No Cost Venclexta (venetoclax) is a targeted oral therapy used to treat certain blood cancers, including chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), by blocking a protein called BCL-2 that helps cancer cells survive. The **Genentech Patient Foundation** offers this medication **free for up to one year** to eligible uninsured or underinsured patients in the US who meet specific income guidelines, helping remove financial barriers to life-saving treatment.[1][2][4][5] ## Who Qualifies for the Program? The Genentech Patient Foundation is designed for patients facing high costs for Genentech medicines like Venclexta. Key eligibility includes: - **Residency**: Must live in the United States and be treated by a US-licensed physician. No citizenship or immigration status is required.[4] - **Insurance Status**: Uninsured, insured but lacking coverage for Venclexta, or insured but unable to afford out-of-pocket costs (e.g., if copays or out-of-pocket maximum exceed 7.5% of yearly income).[1][4] - **Income Limits**: Household income must fall below these thresholds—no Federal Poverty Level (FPL) percentage specified, but fixed amounts apply. Add $25,000 for each additional household member beyond the base.[provided data][4] ### Income Eligibility Breakdown | Household Size | Maximum Annual Income | |----------------|-----------------------| | 1 (Individual) | $75,000 | | 2 (Couple) | $100,000 | | 3 | $125,000 | | 4 | $150,000 | | 5+ | Add $25,000 per extra person; no maximum size | *Notes*: Income is based on total household earnings. Some exceptions may apply—call (888) 941-3331 to confirm.[provided data][4] ## About Venclexta (venetoclax) **Venclexta** is a once-daily tablet taken at home, often with other medications, to target and kill cancer cells in blood cancers. Common uses include: - CLL/SLL in combination with other therapies for relapsed/refractory cases or specific genetic mutations. - AML in newly diagnosed patients over 75 or with comorbidities, combined with azacitidine, decitabine, or low-dose cytarabine. Dosing starts low to minimize tumor lysis syndrome risk (a side effect from rapid cancer cell breakdown), gradually ramping up under doctor supervision. Always follow your prescriber's instructions. This program covers the medication cost but not doctor visits or other care—explore Genentech Access Solutions for broader support at (866) 422-2377.[1][6] ## Insurance Requirements - **Uninsured**: Fully eligible if income qualifies.[1] - **Underinsured**: Eligible if your plan doesn't cover Venclexta, denies it, or if copays/out-of-pocket max >7.5% of income. Medicare patients qualify if they can't afford costs—proof of denial or high costs may help, but appeals aren't required for application.[4][7] - **Government Insurance**: Medicare, Medicaid, etc., patients can apply if unaffordable. The program doesn't require proof of appeal.[7] Contact your insurer first to confirm coverage, as the Foundation verifies this.[1][6] ## Step-by-Step Application Process Applying is straightforward with **multiple methods**. Both **Patient Consent Form** (you complete) and **Prescriber Foundation Form** (your doctor completes) are **required**—no action until both received.[2][3][5] 1. **Check Eligibility**: Use the income table or call (888) 941-3331 (Mon-Fri, 6am-5pm PT) for a Foundation Specialist to guide you.[7] 2. **Gather Documents**: - Proof of income (e.g., tax returns, pay stubs). - Proof of residency (e.g., utility bill). - Valid prescription for Venclexta. - Insurance info/status (e.g., denial letter if applicable).[provided data] 3. **Complete Forms**: - **Patient**: Fill Patient Consent Form (English/Spanish) online at GenentechPatientFoundation.com, print/sign, or via My Patient Solutions if registered.[2][3] - **Prescriber**: Doctor completes Prescriber Foundation Form, including diagnosis codes, treatment info, and signature. E-prescribe if possible (query MedVantx/AmeriPharm, NPI 1235371535).[1] 4. **Submit** (multiple options): - **Online**: eSubmit at GenentechPatientFoundation.com or My Patient Solutions.[2][3][9] - **Fax**: (833) 999-4363—both forms together for speed.[1][2][5] - **Text**: Photo of signed Patient Consent to (650) 877-1111.[2][3] - **Phone Start**: Call (888) 941-3331 for help.[provided data][7] Your doctor’s office handles much of this—inform them you're applying.[2] ## Timeline and Delivery - **Processing**: Within **5 business days** of receiving both forms. You and your prescriber are contacted with outcome/next steps.[2][3] - **Delivery**: Free medication shipped to **your home**, **physician's office**, or **treatment site**. Options: upfront shipments or product replacement (doctor uses inventory, Foundation reimburses). Up to **1 year supply** initially.[1][5] - **Refills**: **Reauthorization required** annually or as needed—resubmit forms if still eligible.[provided data][5] ## Alternatives if Denied - **Appeal/Retry**: Fix issues (e.g., income proof) and reapply. Call for feedback.[3] - **Other Genentech Support**: Genentech Access Solutions for copay help, coverage navigation (866-422-2377).[3][6] - **External Programs**: Check NeedyMeds, PAN Foundation, or state assistance. No biosimilars for Venclexta listed.[provided data] - **Discuss with Doctor**: Sample doses, payment plans, or generics if appropriate. ## Disclaimer This guide is for informational purposes based on available program details as of 2026 and is not medical/financial advice. Eligibility can change—verify with Genentech at (888) 941-3331. Consult your doctor for treatment suitability. Genentech reserves rights to modify program anytime. Income thresholds subject to exceptions.[1][2][4][5]

Program information last verified: March 25, 2026